Predictors of Gastrointestinal Bleeding Among Patients With Atrial Fibrillation Initiating Dabigatran and Subsequent Patterns of Use

Trial Profile

Predictors of Gastrointestinal Bleeding Among Patients With Atrial Fibrillation Initiating Dabigatran and Subsequent Patterns of Use

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Oct 2015

At a glance

  • Drugs Dabigatran etexilate (Primary)
  • Indications Embolism; Stroke
  • Focus Adverse reactions
  • Most Recent Events

    • 08 Oct 2015 New trial record
    • 26 Aug 2015 Results presented at the 31st International Conference on Pharmacoepidemiology and Therapeutic Risk Management.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top